Skip to content

13F-HR filed by Integral Health Asset Management, LLC

Integral Health Asset Management, LLC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 60 holding rows worth $333,932,000.

Accession
0001420506-20-000928
Filed
2020-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 60 entries on the cover page, a total value of $333,932,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $333,932,000 with VALUE read as thousands by filing date, 13F file number 028-19946. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LHC GROUP50187A107COM125,000$21,790,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock120,000$13,675,000thousands by filing date
Bristol-Myers Squibb Company110122108COM200,000$11,760,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW175,000$11,016,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM80,000$9,867,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM55,000$9,589,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS75,000$9,204,000thousands by filing date
CENCORA INC COM03073E105Stock90,000$9,069,000thousands by filing date
NEVRO CORP64157F103COM75,000$8,960,000thousands by filing date
CHEMOCENTRYX INC16383L106COM150,000$8,631,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM110,000$8,580,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM195,000$8,108,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM150,000$8,022,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW340,000$8,014,000thousands by filing date
Danaher Corporation235851102COM45,000$7,957,000thousands by filing date
HUMANA INC COM444859102Stock20,000$7,755,000thousands by filing date
SEATTLE GENETICS INC812578102COM45,000$7,646,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock12,000$7,484,000thousands by filing date
CATALENT INC USD 0.01148806102COM100,000$7,330,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM40,000$7,119,000thousands by filing date
NUVASIVE INC670704105COM125,000$6,958,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR125,000$6,611,000thousands by filing date
DEXCOM INC COM252131107Stock15,000$6,081,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock65,000$6,038,000thousands by filing date
Amgen Inc.031162100COM25,000$5,897,000thousands by filing date
Merck & Co.,Inc.58933Y105COM75,000$5,800,000thousands by filing date
Eli Lilly and Company532457108COM35,000$5,746,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM50,000$5,709,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM150,000$4,991,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock55,000$4,782,000thousands by filing date
Abbott Laboratories002824100COM50,000$4,572,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS80,000$4,446,000thousands by filing date
BAXTER INTL INC071813109COM50,000$4,305,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock35,000$4,178,000thousands by filing date
MCKESSON CORP COM58155Q103Stock25,000$3,836,000thousands by filing date
ENVISTA HOLDINGS CORPORATION29415F104COM175,000$3,691,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock135,000$3,619,000thousands by filing date
EXELIXIS INC COM30161Q104Stock150,000$3,561,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock270,000$3,510,000thousands by filing date
INSULET CORP COM45784P101Stock18,000$3,497,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK250,000$3,395,000thousands by filing date
MODERNA INC60770K957PUT50,000$3,211,000thousands by filing dateput
DENALI THERAPEUTICS INC COM24823R105Stock130,000$3,143,000thousands by filing date
REVVITY INC714046109COM30,000$2,943,000thousands by filing date
CHANGE HEALTHCARE INC15912K100COM250,000$2,800,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM110,000$2,794,000thousands by filing date
INTRA CELLULAR THERAPIES INC46116X901CALL100,000$2,567,000thousands by filing datecall
AbbVie,Inc.00287Y109COM25,000$2,455,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM20,000$2,440,000thousands by filing date
ZOGENIX INC.98978L204Common Stock90,000$2,431,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW350,000$2,422,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM70,000$2,402,000thousands by filing date
MACROGENICS INC556099109COM70,000$1,954,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR10,000$1,884,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM40,000$1,696,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM30,000$1,522,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM100,000$1,471,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM75,000$1,421,000thousands by filing date
INCYTE CORP COM45337C102Stock10,000$1,040,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122157RIGHT 99/99/9999150,000$537,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-20-000928this filing2020-08-14acceptance time not in the bulk data set